Joshua J Gagne
Joshua J Gagne
Associate Professor | Harvard Medical School | Harvard T.H. Chan School of Public Health
Dirección de correo verificada de - Página principal
Citado por
Citado por
A combined comorbidity score predicted mortality in elderly patients better than existing scores
JJ Gagne, RJ Glynn, J Avorn, R Levin, S Schneeweiss
Journal of clinical epidemiology 64 (7), 749-759, 2011
Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis
JJ Gagne, MC Power
Neurology 74 (12), 995-1002, 2010
Development of a comorbidity index for use in obstetric patients
BT Bateman, JM Mhyre, S Hernandez-Diaz, KF Huybrechts, MA Fischer, ...
Obstetrics and gynecology 122 (5), 2013
Effects of adjusting for instrumental variables on bias and precision of effect estimates
JA Myers, JA Rassen, JJ Gagne, KF Huybrechts, S Schneeweiss, ...
American journal of epidemiology 174 (11), 1213-1222, 2011
The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis
MC Power, J Weuve, JJ Gagne, MB McQueen, A Viswanathan, D Blacker
Epidemiology (Cambridge, Mass.) 22 (5), 646, 2011
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis
AS Kesselheim, MR Stedman, EJ Bubrick, JJ Gagne, AS Misono, JL Lee, ...
Drugs 70, 605-621, 2010
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study
JJ Gagne, NK Choudhry, AS Kesselheim, JM Polinski, D Hutchins, ...
Annals of internal medicine 161 (6), 400-407, 2014
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation
S Schneeweiss, JJ Gagne, AR Patrick, NK Choudhry, J Avorn
Circulation: Cardiovascular Quality and Outcomes 5 (4), 480-486, 2012
Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development
S Schneeweiss, JJ Gagne, RJ Glynn, M Ruhl, JA Rassen
Clinical Pharmacology & Therapeutics 90 (6), 777-790, 2011
Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0
SV Wang, S Schneeweiss, ML Berger, J Brown, F de Vries, I Douglas, ...
Value in health 20 (8), 1009-1022, 2017
Innovative research methods for studying treatments for rare diseases: methodological review
JJ Gagne, L Thompson, K O’Keefe, AS Kesselheim
Bmj 349, 2014
Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy
JJ Gagne, V Maio, V Berghella, DZ Louis, JS Gonnella
European journal of clinical pharmacology 64, 1125-1132, 2008
Prevalence and predictors of potential drug–drug interactions in Regione Emilia‐Romagna, Italy
JJ Gagne, V Maio, C Rabinowitz
Journal of clinical pharmacy and therapeutics 33 (2), 141-151, 2008
Role of disease risk scores in comparative effectiveness research with emerging therapies
RJ Glynn, JJ Gagne, S Schneeweiss
Pharmacoepidemiology and drug safety 21, 138-147, 2012
Matching weights to simultaneously compare three treatment groups: comparison to three-way matching
K Yoshida, S Hernández-Díaz, DH Solomon, JW Jackson, JJ Gagne, ...
Epidemiology (Cambridge, Mass.) 28 (3), 387, 2017
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study
BT Bateman, K Bykov, NK Choudhry, S Schneeweiss, JJ Gagne, ...
Bmj 347, 2013
How many “me-too” drugs is too many?
JJ Gagne, NK Choudhry
Jama 305 (7), 711-712, 2011
Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
SR Mostaghim, JJ Gagne, AS Kesselheim
bmj 358, 2017
Refilling and switching of antiepileptic drugs and seizure‐related events
JJ Gagne, J Avorn, WH Shrank, S Schneeweiss
Clinical Pharmacology & Therapeutics 88 (3), 347-353, 2010
Availability of comparative efficacy data at the time of drug approval in the United States
NH Goldberg, S Schneeweiss, MK Kowal, JJ Gagne
JAMA 305 (17), 1786-1789, 2011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20